Dublin, Ireland, 19th January, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback